Two-year outcomes of episcleral brachytherapy adjunct to anti-VEGF therapy for treatment-resistant nAMD.
Jay ChhablaniRama JagerJoshua OngRyan LohrenzRussell J HamiltonBaldassare SteaMary DrewGregg Kokamenull nullPublished in: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie (2022)
The results from this six-subject cohort with 2-year data support additional investigations of ESB for nAMD, specifically those with persistent disease activity and treatment resistant nAMD.
Keyphrases
- disease activity
- systemic lupus erythematosus
- rheumatoid arthritis
- rheumatoid arthritis patients
- ankylosing spondylitis
- high dose
- juvenile idiopathic arthritis
- radiation therapy
- vascular endothelial growth factor
- electronic health record
- endothelial cells
- locally advanced
- squamous cell carcinoma
- low dose
- type diabetes
- metabolic syndrome
- artificial intelligence
- data analysis
- finite element